Literature DB >> 3934271

Rapid stereospecific stimulation of lymphocytic metabolism by interleukin 2.

E O Maddock, S W Maddock, V E Kelley, T B Strom.   

Abstract

IL 2 maintains the viability of IL 2-dependent CTLL-2 cells. IL 2, a lymphocytotrophic factor, stimulates the cellular metabolism of IL 2 receptor-bearing CTLL-2 murine cytolytic T cells. Both aerobic (oxygen consumption) and anaerobic (lactic acid production) metabolism of CTLL-2 cell are stimulated by rIL 2. The effects of IL 2 upon murine T cells is blocked by an anti-IL 2 receptor monoclonal antibody but not by other monoclonal antibodies that bind to other proteins upon CTLL-2 cells. Changes in aerobic and anaerobic cellular metabolism occur rapidly after interaction with IL 2, whereas the effects on the cell cycle are relatively slow and may be dependent upon antecedent metabolic stimulation by IL 2. This effect of IL 2 on cell viability appears to be mediated by a direct effect on important aerobic and anaerobic metabolic pathways.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3934271

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Apparent interleukin 2 (IL-2) inhibitory activity of human serum is due to rapid killing of IL-2-dependent mouse cells.

Authors:  S B Pruett; A Lackey
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

2.  Regulation of interleukin 2-dependent growth responses by glycosylphosphatidylinositol molecules.

Authors:  I Merida; J C Pratt; G N Gaulton
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

Review 3.  Regulation of lymphocyte growth by antagonists of interleukin-2 or its cellular receptor.

Authors:  G N Gaulton; J F Markmann
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

4.  Dissociating STAT4 and STAT5 Signaling Inhibitory Functions of SOCS3: Effects on CD8 T Cell Responses.

Authors:  Ji Young Hwang; John E Holland; Kristine B Valenteros; Yanbo Sun; Young-Kwang Usherwood; Andreia F Verissimo; Jason S McLellan; Gevorg Grigoryan; Edward J Usherwood
Journal:  Immunohorizons       Date:  2019-11-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.